Limestone Investment Advisors’s Liminatus Pharma, Inc. Warrants LIMNW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.41K Buy
+22,562
New +$5.41K ﹤0.01% 131